<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01083433</url>
  </required_header>
  <id_info>
    <org_study_id>RBCDM-01</org_study_id>
    <secondary_id>MH018830</secondary_id>
    <nct_id>NCT01083433</nct_id>
  </id_info>
  <brief_title>Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes</brief_title>
  <official_title>Intensive Diabetes Clinic and Intermittent Continuous Glucose Monitoring in Adolescents With Type 1 Diabetes Mellitus in Poor Glycemic Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals Cleveland Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospitals Cleveland Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to find out ways to help pre-teens and teens and their
      families to improve diabetes control and to help with the burden of diabetes management.
      Specifically, the study aims to find out if coming to diabetes clinic more frequently and for
      a longer period of time helps adolescents with diabetes, and if adolescents who wear a
      continuous glucose monitor (CGM) for 3-5 days a month will have better diabetes control.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Good glycemic control is critical in preventing chronic complications of type 1 diabetes.
      However, achieving good glycemic control remains elusive for many adolescents. This study
      evaluates two clinic-based approaches for improving glycemic control in adolescents with
      poorly controlled type 1 diabetes - an intensive diabetes support and education program alone
      and the same intensive diabetes support and education program together with continuous
      glucose monitoring - in comparison with standard diabetes care.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycemic Control</measure>
    <time_frame>Baseline and then every month for four months</time_frame>
    <description>Serum hemoglobin A1c (HbA1c) will be measured in all groups at the baseline visit and visit 4. Rapid HbA1c using capillary blood will be measured at every visit. Blood glucose meter average will be obtained at every visit. Emergency room visits, hospital admissions, and emergency phone calls for hyperglycemia and ketonuria will be tracked.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin dose changes</measure>
    <time_frame>Baseline and every month for four months</time_frame>
    <description>Insulin doses in units per kilogram per day will be calculated at each visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Episodes of Hypoglycemia (blood glucose &lt;70 mg/dL)</measure>
    <time_frame>Every month for four months</time_frame>
    <description>Blood glucose meter downloads will be used to tabulate the number of episodes of blood glucoses &lt; 70 mg/dL. At each visit patients will be asked to recall any episodes of severe hypoglycemia that occurred since the last visit. Data from the continuous glucose monitors will be used to evaluate the percent of time that patients are below 70 mg/dL and the number of glucose excursions below 70 mg/dL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemic Variability</measure>
    <time_frame>Baseline and month 4</time_frame>
    <description>Glycemic variability will be evaluated from data from continuous glucose monitor downloads.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to prescribed diabetes regimen</measure>
    <time_frame>Baseline and every month for four months</time_frame>
    <description>Adherence will be measured using the Diabetes Self Management Profile, the Self Care Inventory, average number of blood glucose tests the patient completes per day, the amount of time the patient wears the continuous glucose monitor, number of missed insulin injections, insulin usage, and clinic attendance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with intensive diabetes clinic and usage of the continuous glucose monitor</measure>
    <time_frame>Month 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Knowledge</measure>
    <time_frame>Baseline and month 4</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Standard Diabetes Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will attend diabetes clinic as usual, once every 3 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intensive Diabetes Clinic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will attend diabetes clinic on a monthly basis for 4 months in a row. Each patient will have a 30 minute visit with a physician, 30 minutes dedicated to diabetes education, and 45 minutes with a child psychologist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intensive Diabetes Clinic plus CGM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will include all procedures as listed for group 2 (intensive diabetes clinic) in addition to wearing a continuous glucose monitor for 3-5 days each month. Patients will also have an additional 30 minutes with a psychology graduate student dedicated to adherence with the CGM.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diabetes related psychological counseling and education</intervention_name>
    <description>The psychology intervention is based in part on an intervention to maintain parental support for diabetes care in adolescence which was developed by Anderson and colleagues (1999). The first session will include education to parents and children regarding the importance of sharing responsibility for treatment related tasks. The second session will include a discussion of the treatment sharing plan developed at the first visit and problems that may have occurred will be discussed. The third session will include a discussion of planning for possible future problems. Visits 1, 2, and 3 will include 30 minutes of diabetes education.</description>
    <arm_group_label>Intensive Diabetes Clinic</arm_group_label>
    <arm_group_label>Intensive Diabetes Clinic plus CGM</arm_group_label>
    <other_name>Diabetes Education</other_name>
    <other_name>Diabetes Psychological Counseling</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous Glucose Monitor</intervention_name>
    <description>Patients in the intensive diabetes clinic plus CGM group will wear the iPro after the baseline visit followed by every month for 4 months.</description>
    <arm_group_label>Intensive Diabetes Clinic plus CGM</arm_group_label>
    <other_name>Medtronic Minimed iPro</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 diabetes mellitus of at least 12 months duration, followed by Rainbow Babies
             and Children's Pediatric Endocrinology and Diabetes Division

          -  Most recent HbA1c &gt;= 8.5%

          -  Patients must be willing to check their blood sugar at least 4 times daily while
             wearing the CGM

          -  Patients and families must be willing to come to diabetes clinic once a month for 4
             months

        Exclusion Criteria:

          -  Inability to understand and/or speak the English language

          -  Pregnancy

          -  Psychological counseling with Dr. Rebecca Hazen regarding diabetes adherence prior to
             the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah A MacLeish, D.O.</last_name>
    <role>Principal Investigator</role>
    <affiliation>UHCMC Division of Pediatric Endocrinology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rebecca A Hazen, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>UHCMC Division of Behavioral Pediatrics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Leona Cuttler, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>UHCMC Division of Pediatric Endocrinology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rose Gubitosi-Klug, M.D, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>UHCMC Division of Pediatric Endocrinology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UHCMC</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30;329(14):977-86.</citation>
    <PMID>8366922</PMID>
  </reference>
  <reference>
    <citation>Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006 Apr 12;295(14):1681-7.</citation>
    <PMID>16609090</PMID>
  </reference>
  <reference>
    <citation>Monnier L, Colette C. Glycemic variability: should we and can we prevent it? Diabetes Care. 2008 Feb;31 Suppl 2:S150-4. doi: 10.2337/dc08-s241.</citation>
    <PMID>18227477</PMID>
  </reference>
  <reference>
    <citation>Weber C, Schnell O. The assessment of glycemic variability and its impact on diabetes-related complications: an overview. Diabetes Technol Ther. 2009 Oct;11(10):623-33. doi: 10.1089/dia.2009.0043. Review.</citation>
    <PMID>19821754</PMID>
  </reference>
  <reference>
    <citation>El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med. 2008 Sep 29;205(10):2409-17. doi: 10.1084/jem.20081188. Epub 2008 Sep 22. Erratum in: J Exp Med. 2008 Oct 27;205(11):2683.</citation>
    <PMID>18809715</PMID>
  </reference>
  <reference>
    <citation>Hirsch IB. Glycemic variability: it's not just about A1C anymore! Diabetes Technol Ther. 2005 Oct;7(5):780-3. Review.</citation>
    <PMID>16241882</PMID>
  </reference>
  <reference>
    <citation>Monnier L, Colette C, Owens DR. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol. 2008 Nov;2(6):1094-100.</citation>
    <PMID>19885298</PMID>
  </reference>
  <reference>
    <citation>Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006 Dec;29(12):2730-2.</citation>
    <PMID>17130215</PMID>
  </reference>
  <reference>
    <citation>Schaepelynck-BÃ©licar P, Vague P, Simonin G, Lassmann-Vague V. Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS). Diabetes Metab. 2003 Dec;29(6):608-12.</citation>
    <PMID>14707890</PMID>
  </reference>
  <reference>
    <citation>Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008 Oct 2;359(14):1464-76. doi: 10.1056/NEJMoa0805017. Epub 2008 Sep 8.</citation>
    <PMID>18779236</PMID>
  </reference>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2010</study_first_submitted>
  <study_first_submitted_qc>March 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2010</study_first_posted>
  <last_update_submitted>June 12, 2012</last_update_submitted>
  <last_update_submitted_qc>June 12, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospitals Cleveland Medical Center</investigator_affiliation>
    <investigator_full_name>Sarah A. MacLeish</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <keyword>Continuous Glucose Monitor</keyword>
  <keyword>Adherence</keyword>
  <keyword>Adolescents</keyword>
  <keyword>Diabetes Education</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>December 3, 2015</submitted>
    <returned>January 7, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

